Molecular Data Inc is a chemicals business based in the US. Molecular Data shares (MKD) are listed on the NASDAQ and all prices are listed in US Dollars. Molecular Data employs 189 staff and has a trailing 12-month revenue of around $4.6 billion.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $0.02 |
|---|---|
| 52-week range | $0.00 - $6.98 |
| 50-day moving average | $0.45 |
| 200-day moving average | $0.37 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.85 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.0173 from 2022-09-23
| 1 week (2022-09-13) | -40.14% |
|---|---|
| 1 month (2022-08-20) | N/A |
| 3 months (2022-06-24) | -97.34% |
| 6 months (2022-03-20) | N/A |
| 1 year (2021-09-24) | -94.04% |
|---|---|
| 2 years (2020-09-24) | -98.52% |
| 3 years (2019-09-20) | N/A |
| 5 years (2017-09-20) | N/A |
| Revenue TTM | $4.6 billion |
|---|---|
| Gross profit TTM | $-10,199,000 |
| Return on assets TTM | -21.43% |
| Return on equity TTM | -4936.16% |
| Profit margin | -5.54% |
| Book value | N/A |
| Market capitalisation | $5.1 million |
TTM: trailing 12 months
We're not expecting Molecular Data to pay a dividend over the next 12 months.
Molecular Data's shares were split on a 1:15 basis on 22 May 2022. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Molecular Data shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Molecular Data shares which in turn could have impacted Molecular Data's share price.
Over the last 12 months, Molecular Data's shares have ranged in value from as little as $0.0007 up to $6.975. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Molecular Data's is 1.164. This would suggest that Molecular Data's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Molecular Data Inc. , through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase. com and molbase. cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.